Literature DB >> 25875602

Angiogenesis in bronchial asthma.

Krzysztof Pałgan1, Zbigniew Bartuzi2.   

Abstract

Bronchial asthma is a chronic inflammatory disease characterised by airflow obstruction that may be reversed spontaneously or in response to treatment. The airway inflammation can lead to structural changes and remodelling consisting of subepithelial layer thickening, airway smooth muscle hyperplasia and angiogenesis. Subepithelial hypervascularity and angiogenesis in the airways are part of the structural airway wall in asthma. Increased vascularity of bronchial mucosa is closely related to the expression of angiogenic factors like vascular endothelial growth factor (VEGF), angiopoietin and hypoxia-inducible factor (HIF). The scope of the present review is to summarise the roles of anagiogenic factors and treatment in vascular development.
© The Author(s) 2015.

Entities:  

Keywords:  HIF; VEGF; angiogenesis; angiopoietin; asthma

Mesh:

Substances:

Year:  2015        PMID: 25875602     DOI: 10.1177/0394632015580907

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  8 in total

1.  Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.

Authors:  Sabag D Adi; Nasren Eiza; Jacob Bejar; Hila Shefer; Shira Toledano; Ofra Kessler; Gera Neufeld; Elias Toubi; Zahava Vadasz
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 2.  Research advances in airway remodeling in asthma: a narrative review.

Authors:  Yanmei Huang; Chen Qiu
Journal:  Ann Transl Med       Date:  2022-09

3.  Omalizumab improves forced expiratory volume in 1 second in patients with severe asthma.

Authors:  Krzysztof Pałgan; Magdalena Żbikowska-Götz; Kinga Lis; Elżbieta Chrzaniecka; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

4.  Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity.

Authors:  Wenxian Ma; Qiaoyan Jin; Haiqin Guo; Xinpeng Han; Lingbin Xu; Shemin Lu; Changgui Wu
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.988

5.  ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway.

Authors:  Zhen Ding; Fei Yu; Yan Sun; Ning Jiao; Lina Shi; Jinghong Wan; Qinghua Liu
Journal:  Front Pediatr       Date:  2022-02-16       Impact factor: 3.418

6.  ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway.

Authors:  Fang Yan; Xin Hu; Long He; Kegang Jiao; Yanyan Hao; Jing Wang
Journal:  Can Respir J       Date:  2022-08-31       Impact factor: 2.130

7.  Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.

Authors:  Takayuki Okumo; Atsuko Furuta; Tarou Kimura; Kanako Yusa; Kazuhito Asano; Masataka Sunagawa
Journal:  Medicines (Basel)       Date:  2021-05-12

8.  Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate.

Authors:  Shan Shan; Yan Li; Jingjing Wang; Zhe Lv; Dawei Yi; Qiong Huang; Chris J Corrigan; Wei Wang; Zhang Quangeng; Sun Ying
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.